Results 71 to 80 of about 40,797 (259)

Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study

BMJ Medicine
Objective To determine the balance of costs, risks, and benefits for different thromboprophylaxis strategies for medical patients during hospital admission.Design Decision analysis modelling study.Setting NHS hospitals in England.Population Eligible ...
Daniel Horner, Steve Goodacre, Kerstin de Wit, Beverley J Hunt, Abdullah Pandor, Sarah Davis, Mark Holland, Xavier Luke Griffin   +7 more
doaj   +1 more source

Underutilization of pharmacological thromboprophylaxis in obstetrics and gynaecology patients in the absence of a risk assessment tool

Journal of Taibah University Medical Sciences, 2018
Objective: This study was conducted to determine the risk factors for developing venous thromboembolism and to evaluate adherence to thromboprophylaxis guidelines among patients hospitalized in Obstetrics and Gynaecology units.
Galila F. Zaher, FRCPath
doaj   +1 more source

Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients: A Machine Learning Approach [PDF]

, 2017
OBJECTIVE: To design a precision medicine approach aimed at exploiting significant patterns in data, in order to produce venous thromboembolism (VTE) risk predictors for cancer outpatients that might be of advantage over the currently recommended model ...
Ferroni, Patrizia, Guadagni, Fiorella, Nanni, Umberto, Riondino, Silvia, Roselli, Mario, Scarpato, Noemi, Zanzotto, Fabio Massimo   +6 more
core   +1 more source

Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis

New England Journal of Medicine, 2019
Background Whether adjunctive intermittent pneumatic compression in critically ill patients receiving pharmacologic thromboprophylaxis would result in a lower incidence of deep‐vein thrombosis than pharmacologic thromboprophylaxis alone is uncertain ...
Y. Arabi, F. Al-Hameed, K. Burns, S. Mehta, S. Alsolamy, M. Alshahrani, Y. Mandourah, G. Almekhlafi, M. Almaani, A. Al bshabshe, S. Finfer, Zia Arshad, I. Khalid, Y. Mehta, A. Gaur, H. Hawa, H. Buscher, H. Lababidi, A. Al Aithan, S. Abdukahil, J. Jose, Lara Y. Afesh, A. Al-Dawood   +22 more
semanticscholar   +1 more source

Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation

Health Technology Assessment, 2019
Background: Thromboprophylaxis can reduce the risk of venous thromboembolism (VTE) during lower-limb immobilisation, but it is unclear whether or not this translates into meaningful health benefit, justifies the risk of bleeding or is cost-effective ...
Abdullah Pandor, Daniel Horner, Sarah Davis, Steve Goodacre, John W Stevens, Mark Clowes, Beverley J Hunt, Tim Nokes, Jonathan Keenan, Kerstin de Wit   +9 more
doaj   +1 more source

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

Swiss Medical Weekly, 2020
AIMS OF THE STUDY Many centres have noticed a high number of venous thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia.
Pierre Fontana, Alessandro Casini, Helia Robert-Ebadi, Frederic Glauser, Marc Righini, Marc Blondon   +5 more
doaj   +1 more source

Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study

Research and Practice in Thrombosis and Haemostasis, 2022
Background and Objectives Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standard doses ...
Kathleen M. Andersen, Corey S. Joseph, Hemalkumar B. Mehta, Michael B. Streiff, Joshua F. Betz, Robert C. Bollinger Jr, Arielle M. Fisher, Amita Gupta, Charles F. LeMaistre, Matthew L. Robinson, Yanxun Xu, Derek K. Ng, G. Caleb Alexander, Brian T. Garibaldi   +13 more
doaj   +1 more source

Arterial complications, venous thromboembolism and deep venous thrombosis prophylaxis after anterior cruciate ligament reconstruction: A systematic review [PDF]

, 2016
AIM To summarize the current knowledge on vascular complications and deep venous thrombosis (DVT) prophylaxis after anterior cruciate ligament (ACL) reconstruction.
Janssen, D.M. (Daan Martijn), Janssen, R.P.A. (Rob), Reijman, M. (Max), van Mourik, J.B.A. (Jan Bernardus Antonius)   +3 more
core   +3 more sources

Improvement of Perioperative Management of Patients Undergoing Surgical Treatment for Hip Periprosthetic Joint Infection

Travmatologiâ i Ortopediâ Rossii, 2021
Two-stage revision arthroplasty in chronic hip periprosthetic joint infection cases is the “gold standard” treatment. First stage debridement leads to large intraoperative and drainage blood loss using standard protocols for thromboprophylaxis and ...
A. A. Kochish, S. A. Bozhkova, V. A. Artyukh, V. N. Liventsov, A. V. Afanas’ev, S. S. Toropov   +5 more
doaj   +1 more source

Perioperative Thromboprophylaxis [PDF]

Visceral Medicine, 2013
<b><i>Background: </i></b>Venous thromboembolism (VTE), a composite of deep vein thrombosis and pulmonary embolism, is a preventable cause of morbidity and mortality in surgical patients. <b><i>Method: </i></b>National and international treatment guidelines and major clinical trials on mechanical or ...
openaire   +1 more source